NO882917D0 - Fusjonsproteiner og partikler. - Google Patents
Fusjonsproteiner og partikler.Info
- Publication number
- NO882917D0 NO882917D0 NO1988882917A NO882917A NO882917D0 NO 882917 D0 NO882917 D0 NO 882917D0 NO 1988882917 A NO1988882917 A NO 1988882917A NO 882917 A NO882917 A NO 882917A NO 882917 D0 NO882917 D0 NO 882917D0
- Authority
- NO
- Norway
- Prior art keywords
- particles
- fusion proteins
- fusion
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868626148A GB8626148D0 (en) | 1986-11-01 | 1986-11-01 | Antigen presentation & purification system |
GB878708531A GB8708531D0 (en) | 1987-04-09 | 1987-04-09 | Fusion proteins & particles |
US07/036,807 US5041385A (en) | 1986-11-01 | 1987-04-10 | Vector expressing fusion proteins and particles |
PCT/GB1987/000764 WO1988003563A1 (en) | 1986-11-01 | 1987-10-28 | Fusion proteins and particles |
Publications (4)
Publication Number | Publication Date |
---|---|
NO882917D0 true NO882917D0 (no) | 1988-06-30 |
NO882917L NO882917L (no) | 1988-08-29 |
NO177793B NO177793B (no) | 1995-08-14 |
NO177793C NO177793C (no) | 1995-11-22 |
Family
ID=27263194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO882917A NO177793C (no) | 1986-11-01 | 1988-06-30 | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0330661B1 (no) |
JP (2) | JP2708046B2 (no) |
AU (1) | AU606896B2 (no) |
CA (1) | CA1339263C (no) |
DE (1) | DE3788807T2 (no) |
ES (1) | ES2010231A6 (no) |
NO (1) | NO177793C (no) |
WO (1) | WO1988003563A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3788806T2 (de) * | 1986-11-01 | 1994-07-07 | British Bio Technology | Kugelförmige hybrid-hiv-antigene. |
US5631154A (en) * | 1988-06-10 | 1997-05-20 | Therion Biologics, Incorporated | Self assembled, defective, non-self-propagating lentivirus particles |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
EP0445227A4 (en) * | 1988-11-23 | 1991-12-27 | The Regents Of The University Of California | Position-specific insertion vectors and method of using same |
WO1990014355A1 (en) * | 1989-05-17 | 1990-11-29 | Research Corporation Technologies, Inc. | Retrovirus-mediated secretion of recombinant products |
DE69029135T2 (de) * | 1989-05-30 | 1997-05-28 | Nippon Zeon Co | Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel |
EP0431128B1 (en) * | 1989-06-01 | 2003-03-26 | Applied Biotechnology, Inc. | Vector coding for self-assembled, defective, non-self-propagating viral particles |
WO1991019803A1 (en) * | 1990-06-19 | 1991-12-26 | Applied Biotechnology, Incorporated | Self assembled, defective, nonself-propagating viral particles |
GB9107631D0 (en) * | 1991-04-10 | 1991-05-29 | British Bio Technology | Proteinaceous particles |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
FR2703996B1 (fr) * | 1993-04-16 | 1995-07-21 | Transgene Sa | Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote. |
US7476517B2 (en) | 1999-06-30 | 2009-01-13 | Evotec Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US20040014033A1 (en) | 1999-06-30 | 2004-01-22 | Evotec Biosystems Ag, A Corporation Of Germany | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
AU6267000A (en) * | 1999-06-30 | 2001-01-22 | Evotec Oai Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
EP1219705B1 (en) * | 2000-12-29 | 2007-11-28 | Evotec AG | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
FI116198B (fi) | 2001-07-16 | 2005-10-14 | Valtion Teknillinen | Polypeptidien immobilisointimenetelmä |
LT5414B (lt) | 2005-04-13 | 2007-04-25 | Biotechnologijos Institutas | Monokloninių antikūnų gavimo būdas, hibridomos, gautos šiuo būdu ir rekombinantinės chimerinės į virusus panašios dalelės su įterptais kitų baltymų fragmentais kaip imunogenai hibridomų gavimui šiuo būdu |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
JPS6193199A (ja) * | 1984-10-13 | 1986-05-12 | Kyowa Hakko Kogyo Co Ltd | 抗インタ−フエロン−γモノクロ−ナル抗体 |
-
1987
- 1987-10-28 WO PCT/GB1987/000764 patent/WO1988003563A1/en active IP Right Grant
- 1987-10-28 JP JP62506664A patent/JP2708046B2/ja not_active Expired - Fee Related
- 1987-10-28 EP EP87906926A patent/EP0330661B1/en not_active Expired - Lifetime
- 1987-10-28 DE DE3788807T patent/DE3788807T2/de not_active Expired - Fee Related
- 1987-10-28 AU AU81057/87A patent/AU606896B2/en not_active Ceased
- 1987-10-30 CA CA000550668A patent/CA1339263C/en not_active Expired - Fee Related
- 1987-10-30 ES ES878703105A patent/ES2010231A6/es not_active Expired
-
1988
- 1988-06-30 NO NO882917A patent/NO177793C/no not_active IP Right Cessation
-
1996
- 1996-05-23 JP JP8128724A patent/JPH09248191A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1339263C (en) | 1997-08-12 |
WO1988003563A1 (en) | 1988-05-19 |
DE3788807D1 (de) | 1994-02-24 |
NO882917L (no) | 1988-08-29 |
AU8105787A (en) | 1988-06-01 |
JPH02501026A (ja) | 1990-04-12 |
EP0330661B1 (en) | 1994-01-12 |
AU606896B2 (en) | 1991-02-21 |
ES2010231A6 (es) | 1989-11-01 |
JP2708046B2 (ja) | 1998-02-04 |
DE3788807T2 (de) | 1994-06-30 |
JPH09248191A (ja) | 1997-09-22 |
NO177793B (no) | 1995-08-14 |
NO177793C (no) | 1995-11-22 |
EP0330661A1 (en) | 1989-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK568487D0 (da) | Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse. | |
DK540289A (da) | Protein | |
DK166087D0 (da) | Proteiner og fremgangsmaade til fremstilling deraf | |
NO162422C (no) | Kampolymerer samt fremstilling og anvendelse derav. | |
DK288184D0 (da) | 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse | |
DK299087D0 (da) | Proteins and derivatives thereof | |
NO882917L (no) | Fusjonsproteiner og partikler. | |
NO881658D0 (no) | Bifunksjonelle proteiner. | |
NO882226D0 (no) | Fibrinolytiske proteiner. | |
DK166583C (da) | 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse | |
DK224985D0 (da) | Peptider, og midler indeholdende peptiderne | |
NO873216D0 (no) | Rekombinante htlv-iii-proteiner og anvendelse derav. | |
DK395288D0 (da) | Proteiner | |
DK203087D0 (da) | Proteiner og fremgangsmaade til fremstilling deraf | |
DK413187A (da) | Semicarbazoner og thiosemicarbazoner | |
NO905561D0 (no) | Proteiner og nukleinsyrer. | |
NO881502D0 (no) | Rekombinante htlv-111 proteiner og anvendelse av disse. | |
IT8719698A0 (it) | Metodo e dispositivo di fusione. | |
NO892948L (no) | Modifiserte proteiner. | |
DK284489A (da) | Fusionsproteiner | |
DK422984D0 (da) | Aminocyklopentaner og farmaceutiske praeparater deraf | |
ATE100146T1 (de) | Fusionsproteine und -partikel. | |
DK362088D0 (da) | Fusionsproteiner og fusionsproteinpartikler | |
DK162089C (da) | 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse | |
NO881501D0 (no) | Rekombinante htlv-111 proteiner og anvendelse av disse. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2003 |